相关实验视频

Updated: May 7, 2025

Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells

Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells

Published on: September 1, 2019

在T细胞急性淋巴细胞白血病 (T-ALL) 和超越的新增强剂

Charlotte Smith^1,2, Vahid Asnafi^1,2, Aurore Touzart^1,2

¹Laboratory of Onco-Hematology, Necker Children's Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.

International journal of cancer

|January 3, 2025

概括

T细胞急性淋巴细胞白血病 (T-ALL) 涉及表观遗传变化,包括形成瘤新增强剂的非编码突变. 本综述探讨了这些突变及其对癌症发展的更广泛影响.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
表观遗传学在表观遗传学中,表观遗传学是指表观遗传学.

背景情况:

T细胞急性淋巴细胞白血病 (T-ALL) 是一种侵袭性血液癌症,影响儿童和成人.
T-ALL的特征是不成熟的T细胞的异常生长,并由转录因子过度表达驱动.
虽然染色体转位很常见,但表观遗传失调,包括基因组修饰变化,也起着作用.

研究的目的:

审查T-ALL.中已知表观遗传激活的基因间突变.
讨论新增强剂突变在T-ALL病变发生过程中的作用.
探索癌症中新增强基因突变的更广泛影响.

主要方法:

在T-ALL.中表观遗传激活基因间突变的文献综述.
分析转录因子和表观遗传修饰的作用.
讨论新增强剂的形成和功能.

主要成果:

确定了特定的非编码性基因间突变,这些突变在T-ALL.中充当瘤新增强剂.
强调了表观遗传失调和T-ALL发育之间的联系.
确立的新增强剂作为T-ALL和潜在的其他癌症的重要机制.

结论:

表观遗传改变,特别是新增强剂突变,是T-ALL的关键驱动因素.
了解这些机制为T-ALL和其他恶性瘤提供了潜在的治疗点.
对新增强剂的进一步研究可以扩大我们对癌症发展的理解.

关键词:

在T-ALL中,所有.在这种情况下,染色染色素新增增强剂的新增强剂在基因上,我们发现了基因上的差异.这是一个超级增强器.

更多相关视频

In Vitro Differentiation Model of Human Normal Memory B Cells to Long-lived Plasma Cells

In Vitro Differentiation Model of Human Normal Memory B Cells to Long-lived Plasma Cells

Published on: January 20, 2019

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

相关概念视频

Non-LTR Retrotransposons

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...